It was reported that bd alaris smartsite needle-free valve had flow issues.The following information was received by the initial reporter in chinese with the verbatim: at 9:20 am on (b)(6) 2023, indwelling needle puncture was performed on the patient, and materials were prepared before operation.The package of the sealed infusion joint without a needle was intact without damage and without air leakage.Within the validity period, after opening the outer package, 10ml was used to pre-charge exhaust gas, but the exhaust gas was not smooth, then the pre-charge was replaced and the exhaust gas was again, and the exhaust gas was still not smooth.Then a new needle-free closed infusion joint was replaced, the exhaust was smooth, and the next operation was carried out for the patient.Physiological response (body temperature: 36.5; breathing: 20 times/min; pulse: 78 beats/min; blood pressure: 116/68mmhg; peripheral blood oxygen saturation: 99%).
|
H.6.Investigation summary: a 2000e china sample was not available for investigation; however, the customer indicated the complaint sample was from lot 23035120.The feedback provided by the customer suggests an occlusion was detected during use of the smartsite device; furthermore the customer appears to indicate the connecting product was a bd product.The details of this feedback were forwarded to the manufacturing site for investigation.A review of the production records for lot 23035120 did not identify any in-process testing failures or quality deviations which may have resulted in a report of this nature.The root cause of the customer¿s experience could not be determined as the sample was not available for investigation.In this instance, without a sample, it is not possible to determine whether a manufacturing defect could have caused or contributed to the customer¿s experience.A review of the customer feedback database indicates that this is a rare occurrence with a small number of similar reports against the smartsite component in the past 12 months.
|